Rights and permissions
About this article
Cite this article
Topotecan + paclitaxel: promising response, tolerability in advanced NSCLC. Inpharma Wkly. 1553, 15 (2006). https://doi.org/10.2165/00128413-200615530-00040
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615530-00040